Ontology type: schema:ScholarlyArticle Open Access: True
2008-09-09
AUTHORSJason I Herschkowitz, Xiaping He, Cheng Fan, Charles M Perou
ABSTRACTIntroductionBreast cancers can be classified using whole genome expression into distinct subtypes that show differences in prognosis. One of these groups, the basal-like subtype, is poorly differentiated, highly metastatic, genomically unstable, and contains specific genetic alterations such as the loss of tumour protein 53 (TP53). The loss of the retinoblastoma tumour suppressor encoded by the RB1 locus is a well-characterised occurrence in many tumour types; however, its role in breast cancer is less clear with many reports demonstrating a loss of heterozygosity that does not correlate with a loss of RB1 protein expression.MethodsWe used gene expression analysis for tumour subtyping and polymorphic markers located at the RB1 locus to assess the frequency of loss of heterozygosity in 88 primary human breast carcinomas and their normal tissue genomic DNA samples.ResultsRB1 loss of heterozygosity was observed at an overall frequency of 39%, with a high frequency in basal-like (72%) and luminal B (62%) tumours. These tumours also concurrently showed low expression of RB1 mRNA. p16INK4a was highly expressed in basal-like tumours, presumably due to a previously reported feedback loop caused by RB1 loss. An RB1 loss of heterozygosity signature was developed and shown to be highly prognostic, and was potentially a predictive marker of response to neoadjuvant chemotherapy.ConclusionsThese results suggest that the functional loss of RB1 is common in basal-like tumours, which may play a key role in dictating their aggressive biology and unique therapeutic responses. More... »
PAGESr75
http://scigraph.springernature.com/pub.10.1186/bcr2142
DOIhttp://dx.doi.org/10.1186/bcr2142
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1005607697
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/18782450
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Oncology and Carcinogenesis",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Breast Neoplasms",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Carcinoma",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Cell Division",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Cyclin D1",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Cyclin-Dependent Kinase Inhibitor p16",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Drug Resistance, Neoplasm",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Female",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Gene Expression Profiling",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Genes, Retinoblastoma",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Genes, bcl-1",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Genes, p16",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Humans",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Loss of Heterozygosity",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Neoadjuvant Therapy",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Neoplasm Proteins",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Oligonucleotide Array Sequence Analysis",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "RNA, Messenger",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "RNA, Neoplasm",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Retinoblastoma Protein",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Department of Molecular and Cellular Biology, Baylor College of Medicine, One Baylor Plaza, DeBakey M635, 77030, Houston, TX, USA",
"id": "http://www.grid.ac/institutes/grid.39382.33",
"name": [
"Lineberger Comprehensive Cancer Center, University of North Carolina, 27599, Chapel Hill, NC, USA",
"Department of Genetics, University of North Carolina, 27599, Chapel Hill, NC, USA",
"Department of Molecular and Cellular Biology, Baylor College of Medicine, One Baylor Plaza, DeBakey M635, 77030, Houston, TX, USA"
],
"type": "Organization"
},
"familyName": "Herschkowitz",
"givenName": "Jason I",
"id": "sg:person.01353272410.70",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01353272410.70"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Genetics, University of North Carolina, 27599, Chapel Hill, NC, USA",
"id": "http://www.grid.ac/institutes/grid.10698.36",
"name": [
"Lineberger Comprehensive Cancer Center, University of North Carolina, 27599, Chapel Hill, NC, USA",
"Department of Genetics, University of North Carolina, 27599, Chapel Hill, NC, USA"
],
"type": "Organization"
},
"familyName": "He",
"givenName": "Xiaping",
"id": "sg:person.012027350517.69",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012027350517.69"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Lineberger Comprehensive Cancer Center, University of North Carolina, 27599, Chapel Hill, NC, USA",
"id": "http://www.grid.ac/institutes/grid.10698.36",
"name": [
"Lineberger Comprehensive Cancer Center, University of North Carolina, 27599, Chapel Hill, NC, USA"
],
"type": "Organization"
},
"familyName": "Fan",
"givenName": "Cheng",
"id": "sg:person.013535365007.00",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013535365007.00"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Pathology & Laboratory Medicine, University of North Carolina, 27599, Chapel Hill, NC, USA",
"id": "http://www.grid.ac/institutes/grid.410711.2",
"name": [
"Lineberger Comprehensive Cancer Center, University of North Carolina, 27599, Chapel Hill, NC, USA",
"Department of Genetics, University of North Carolina, 27599, Chapel Hill, NC, USA",
"Department of Pathology & Laboratory Medicine, University of North Carolina, 27599, Chapel Hill, NC, USA"
],
"type": "Organization"
},
"familyName": "Perou",
"givenName": "Charles M",
"id": "sg:person.0614405557.39",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0614405557.39"
],
"type": "Person"
}
],
"citation": [
{
"id": "sg:pub.10.1007/s00428-002-0695-9",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1044552664",
"https://doi.org/10.1007/s00428-002-0695-9"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1186/1471-2164-7-96",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1015725266",
"https://doi.org/10.1186/1471-2164-7-96"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/bf03256223",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1026791910",
"https://doi.org/10.1007/bf03256223"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/375503a0",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1034728495",
"https://doi.org/10.1038/375503a0"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/35021093",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1033846543",
"https://doi.org/10.1038/35021093"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/bf03401773",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1083393107",
"https://doi.org/10.1007/bf03401773"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1023/a:1010623308275",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1040381205",
"https://doi.org/10.1023/a:1010623308275"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1186/1476-4598-6-7",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1020656455",
"https://doi.org/10.1186/1476-4598-6-7"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/bjc.1998.739",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1051973598",
"https://doi.org/10.1038/bjc.1998.739"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1186/bcr1399",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1000603711",
"https://doi.org/10.1186/bcr1399"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/modpathol.3800528",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1018899345",
"https://doi.org/10.1038/modpathol.3800528"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/sj.onc.1201919",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1029795849",
"https://doi.org/10.1038/sj.onc.1201919"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1186/1471-2156-6-53",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1022501179",
"https://doi.org/10.1186/1471-2156-6-53"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1186/gb-2007-8-5-r76",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1018711468",
"https://doi.org/10.1186/gb-2007-8-5-r76"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/nrc1802",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1046303336",
"https://doi.org/10.1038/nrc1802"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/ng911",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1041714520",
"https://doi.org/10.1038/ng911"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/nature06046",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1037045843",
"https://doi.org/10.1038/nature06046"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/sj.onc.1210450",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1027816001",
"https://doi.org/10.1038/sj.onc.1210450"
],
"type": "CreativeWork"
}
],
"datePublished": "2008-09-09",
"datePublishedReg": "2008-09-09",
"description": "IntroductionBreast cancers can be classified using whole genome expression into distinct subtypes that show differences in prognosis. One of these groups, the basal-like subtype, is poorly differentiated, highly metastatic, genomically unstable, and contains specific genetic alterations such as the loss of tumour protein 53 (TP53). The loss of the retinoblastoma tumour suppressor encoded by the RB1 locus is a well-characterised occurrence in many tumour types; however, its role in breast cancer is less clear with many reports demonstrating a loss of heterozygosity that does not correlate with a loss of RB1 protein expression.MethodsWe used gene expression analysis for tumour subtyping and polymorphic markers located at the RB1 locus to assess the frequency of loss of heterozygosity in 88 primary human breast carcinomas and their normal tissue genomic DNA samples.ResultsRB1 loss of heterozygosity was observed at an overall frequency of 39%, with a high frequency in basal-like (72%) and luminal B (62%) tumours. These tumours also concurrently showed low expression of RB1 mRNA. p16INK4a was highly expressed in basal-like tumours, presumably due to a previously reported feedback loop caused by RB1 loss. An RB1 loss of heterozygosity signature was developed and shown to be highly prognostic, and was potentially a predictive marker of response to neoadjuvant chemotherapy.ConclusionsThese results suggest that the functional loss of RB1 is common in basal-like tumours, which may play a key role in dictating their aggressive biology and unique therapeutic responses.",
"genre": "article",
"id": "sg:pub.10.1186/bcr2142",
"inLanguage": "en",
"isAccessibleForFree": true,
"isFundedItemOf": [
{
"id": "sg:grant.2440139",
"type": "MonetaryGrant"
},
{
"id": "sg:grant.2476788",
"type": "MonetaryGrant"
}
],
"isPartOf": [
{
"id": "sg:journal.1022375",
"issn": [
"1465-5411",
"1465-542X"
],
"name": "Breast Cancer Research",
"publisher": "Springer Nature",
"type": "Periodical"
},
{
"issueNumber": "5",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "10"
}
],
"keywords": [
"basal-like tumors",
"breast carcinoma",
"RB1 loss",
"functional loss",
"unique therapeutic responses",
"luminal B tumors",
"basal-like subtype",
"primary human breast carcinomas",
"human breast carcinoma",
"tumor suppressor",
"tumor protein 53",
"specific genetic alterations",
"neoadjuvant chemotherapy",
"IntroductionBreast cancer",
"B tumors",
"aggressive biology",
"RB1 locus",
"predictive marker",
"therapeutic response",
"breast cancer",
"loss of heterozygosity",
"tumor types",
"RB1 protein expression",
"retinoblastoma tumor suppressor",
"distinct subtypes",
"tumor subtyping",
"tumors",
"low expression",
"ConclusionsThese results",
"protein expression",
"overall frequency",
"genetic alterations",
"protein 53",
"frequency of loss",
"whole genome expression",
"common event",
"carcinoma",
"cancer",
"subtypes",
"RB1 mRNA",
"gene expression analysis",
"genomic DNA samples",
"markers",
"expression",
"DNA samples",
"chemotherapy",
"prognosis",
"high frequency",
"suppressor",
"MethodsWe",
"expression analysis",
"response",
"key role",
"loss",
"p16INK4a",
"subtyping",
"alterations",
"Rb1",
"role",
"genome expression",
"report",
"mRNA",
"heterozygosity",
"group",
"frequency",
"polymorphic markers",
"differences",
"feedback loop",
"occurrence",
"events",
"loci",
"samples",
"biology",
"types",
"analysis",
"results",
"signatures",
"loop"
],
"name": "The functional loss of the retinoblastoma tumour suppressor is a common event in basal-like and luminal B breast carcinomas",
"pagination": "r75",
"productId": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1005607697"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1186/bcr2142"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"18782450"
]
}
],
"sameAs": [
"https://doi.org/10.1186/bcr2142",
"https://app.dimensions.ai/details/publication/pub.1005607697"
],
"sdDataset": "articles",
"sdDatePublished": "2022-06-01T22:07",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-springernature-scigraph/baseset/20220601/entities/gbq_results/article/article_471.jsonl",
"type": "ScholarlyArticle",
"url": "https://doi.org/10.1186/bcr2142"
}
]Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/bcr2142'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/bcr2142'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/bcr2142'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/bcr2142'
This table displays all metadata directly associated to this object as RDF triples.
325 TRIPLES
22 PREDICATES
141 URIs
115 LITERALS
26 BLANK NODES